Oligometastatic NSCLC: Definition and Treatment Opportunities

Posted On 2021-08-26 16:22:46


In this series, several crucial aspects of oligometastatic NSCLC lung cancer (OM-NSCLC) are covered, all pertinent to the management of OMD. We believe that some of this knowledge may become useful in the future for the management of stage IV lung cancer in general.

Editorial on Oligometastatic NSCLC: Definition and Treatment Opportunities
Oligometastatic non-small cell lung cancer: from biology to clinical practice
Maurizio V. Infante, Thierry Berghmans

Local for advanced, is this a paradox?
Maristella Bungaro, Chiara Paratore, Paolo Bironzo, Silvia Novello

Review Article on Oligometastatic NSCLC: Definition and Treatment Opportunities
Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review
Jill F. Mentink, Marthe S. Paats, Daphne W. Dumoulin, Robin Cornelissen, Joris B. W. Elbers, Alexander P. W. M. Maat, Jan H. von der Thüsen, Anne-Marie C. Dingemans

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis
Elisa Gobbini, Luca Bertolaccini, Niccolò Giaj-Levra, Jessica Menis, Matteo Giaj-Levra

Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer
Sawsan Rashdan, Puneeth Iyengar, John D. Minna, David E. Gerber

A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
Lorenzo Belluomini, Alessandra Dodi, Alberto Caldart, Dzenete Kadrija, Marco Sposito, Miriam Casali, Giulia Sartori, Miriam Grazia Ferrara, Alice Avancini, Emilio Bria, Jessica Menis, Michele Milella, Sara Pilotto

Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
Diego Cortinovis, Umberto Malapelle, Fabio Pagni, Alessandro Russo, Giuseppe Luigi Banna, Elisa Sala, Christian Rolfo

Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
Luca Bertolaccini, Monica Casiraghi, Giulia Sedda, Filippo de Marinis, Lorenzo Spaggiari

The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
Lawek Berzenji, Sophie Debaenst, Jeroen M. H. Hendriks, Suresh Krishan Yogeswaran, Patrick Lauwers, Paul E. Van Schil

Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
Nora Sundahl, Yolande Lievens

Alternative methods for local ablation—interventional pulmonology: a narrative review
Gerard Olive, Rex Yung, Henry Marshall, Kwun M. Fong

Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review
Michael C. Tjong, Alexander V. Louie, Puneeth Iyengar, Benjamin J. Solomon, David A. Palma, Shankar Siva

Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review
Vincent Fallet, Lise Matton, Antoine Schernberg, Anthony Canellas, François H. Cornelis, Jacques Cadranel

Current and future research efforts in oligometastatic non-small cell lung cancer—a systematic review
Mariana Brandão, Valérie Durieux, Thierry Berghmans

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
Jordi Remon, Jessica Menis, Antonin Levy, Dirk K. M. De Ruysscher, Lizza E. L. Hendriks

Disclosure:
The series “Oligometastatic NSCLC: definition and treatment opportunities” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Maurizio V. Infante and Thierry Berghmans served as the unpaid Guest Editors for the series.